CureTech Ltd

Industry · 3 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma Primary Hepatocellular Carcinoma	Phase 1 / Phase 2	2009-10-01
Terminated	Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype Chronic Hepatitis C	Phase 1 / Phase 2	2009-09-01
Completed	CT-011 MAb in DLBCL Patients Following ASCT Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Primary Mediastinal Large B-Cell Lymphoma	Phase 2	2007-10-01